Your browser doesn't support javascript.
loading
Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis.
Aziz, Muhammad; Haghbin, Hossein; Abu Sitta, Emad; Nawras, Yusuf; Fatima, Rawish; Sharma, Sachit; Lee-Smith, Wade; Duggan, Joan; Kammeyer, Joel A; Hanrahan, Jennifer; Assaly, Ragheb.
Afiliación
  • Aziz M; Division of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Haghbin H; Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Abu Sitta E; Division of Infectious Disease, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Nawras Y; Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Fatima R; Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Sharma S; Department of Internal Medicine, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Lee-Smith W; University of Toledo Libraries, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Duggan J; Division of Infectious Disease, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Kammeyer JA; Division of Infectious Disease, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Hanrahan J; Division of Infectious Disease, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Assaly R; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Toledo Medical Center, Toledo, Ohio, USA.
J Med Virol ; 93(3): 1620-1630, 2021 03.
Article en En | MEDLINE | ID: mdl-32918755

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: J Med Virol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: J Med Virol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos